Stories
Slash Boxes
Comments

SoylentNews is people

posted by martyb on Monday October 17 2016, @09:05PM   Printer-friendly
from the no-pain-no-gain? dept.

Scientists at the Institute for Problems of Chemical and Energetic Technologies (IPCET) and collaborators have developed tiovyurtsin, a generic drug for the treatment of pain. The new analgesic lacks the side effects typical of steroid and non-steroidal anti-inflammatory drugs.

"As a raw material for the new drug, we used glyoxal—a substance for which the industrial technology of synthesis was developed by chemists at Tomsk State University," said Sergey Sysolyatin, the director of the IPCET SB RAS (a graduate of TSU's Faculty of Chemistry). "High-energy compounds are also based on glyoxal. At the intermediate stage of synthesis, we are withdrawing a small portion of the substance, modifying it, and then obtaining a drug with excellent pharmacological characteristics."

Preclinical tests carried out at the ED Goldberg Research Institute of Pharmacology and Regenerative Medicine (Tomsk) showed that the new analgesic suppresses pain symptoms of various etiologies and has a longer period of effectiveness than other painkillers, with no toxic effects on the body.

This appears to be an update on research reported in January 2016 in Medical Express: New drug could be safer, non-addictive alternative to morphine, which references an abstract appearing in the journal: Neuropharmacology DOI: 10.1016/j.neuropharm.2015.12.024


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 0) by Anonymous Coward on Monday October 17 2016, @09:18PM

    by Anonymous Coward on Monday October 17 2016, @09:18PM (#415421)

    No, it's just a press release, with a side helping of name-dropping and a bunch of Russian institutions google barely knows about